tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences
X

Need an answer now?

Give us a call

Leave a message, we'll get back to you





Get advice about

1 869 results for your search

Split per category

299 Antibodies

296 Primary Antibodies 1 Support Products

4 Arrays

4 Antibody Arrays

127 Assays & Kits

29 Functional Assays 82 Simplex Quantification 12 Support Products 4 Multiplex Quantification

4 Cells, Media & Fractions

1 Media & ECM 3 Cell Lines

41 Expression Vectors

7 Adenovirus 34 ORF expression

13 Genomics

3 DNA Extractions 10 Reporter Assays

32 Lipidomics

32 Lipids

12 miRNA

12 miRNA Assays

991 Molecules

866 Inhibitors & Activators 118 Chemicals 6 Libraries 1 Antibiotics & Metabolites

313 Proteins & Peptides

31 Peptides 222 Proteins

24 Transcriptomics

21 RT-PCR 3 RNA Controls

11 Others

18 blog articles

18 blog articles


Fighting COVID-19 with specific research reagents | tebu-bio's blog Facebook LinkedIn Twitter YouTube

SARS-CoV:ACE2 inhibitor small molecule screening assays | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Inflammatory cytokines, INFs, ELISA, Miltuplex, Antibody Arrays, Cytokine storm, Cytokine release syndrom | tebu-bio's blog Facebook LinkedIn Twitter YouTube

COVID-19: relevant cell culture models | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Robust anti-COVID antibodies for antiviral research | tebu-bio's blog Facebook LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 5 Facebook LinkedIn Twitter YouTube

Human and Viral proteases as targets for SARS-CoV-2 treatment? | tebu-bio's blog Facebook LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 6 Facebook LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 3 Facebook LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 4 Facebook LinkedIn Twitter YouTube

Accelerate your Biomarker discovery with High Density arrays | tebu-bio's blog Facebook LinkedIn Twitter YouTube

PROTACs: A promising strategy in Drug Development | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Immunoprecipitation thanks to the combination of Chromalink and Nanolink technologies | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Immuno-Oncology: 6 must-haves to boost your R&D projects | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Ppc-1 small molecule: a new mitochondria uncoupling agent | tebu-bio's blog Facebook LinkedIn Twitter YouTube

6 good reasons (in short!) to use our blood derived cells! | tebu-bio's blog Facebook LinkedIn Twitter YouTube

Tips to select the best secondary | tebu-bio's blog Facebook LinkedIn Twitter YouTube

ATM or DNA-PKcs inhibitors synthetically lethal in BRCA- cells | tebu-bio's blog Facebook LinkedIn Twitter YouTube